Potassium ion efflux (K+ efflux)

Potassium ion (K+) efflux is a fundamental cellular process involving the movement of potassium ions from the intracellular space to the extracellular environment, driven by a steep concentration gradient [1.3.1, 1.4.1]. This efflux is primarily mediated by a diverse superfamily of potassium channels (including voltage-gated, calcium-activated, and two-pore domain channels) and transporters, as well as non-selective pores formed by toxins or the gasdermin D protein [1.2.1, 1.3.4]. In the field of immunology, K+ efflux is recognized as the "common trigger" and a necessary second signal for the activation of the NLRP3 inflammasome, a multiprotein complex that regulates the maturation and release of pro-inflammatory cytokines such as IL-1β and IL-18 [1.1.1, 1.4.1]. A significant drop in cytosolic K+ concentration (below ~70-90 mM) is required for NLRP3 to undergo the conformational changes and oligomerization necessary for its activation [1.2.2, 1.4.2]. Consequently, the regulation of K+ efflux is a critical checkpoint in the innate immune response and a major focus for therapeutic intervention in chronic inflammatory, autoimmune, and neurodegenerative diseases [1.1.1, 1.2.1]. Drugs that modulate this process include ionophores like nigericin that induce efflux to trigger inflammation, and inhibitors such as glibenclamide or P2X7 receptor antagonists that block efflux to suppress pathological inflammatory signaling [1.2.1, 1.4.1, 1.4.2].

Other names

K+ exitPotassium depletionCytosolic potassium drop

Inhibition of K+ efflux to prevent NLRP3 inflammasome assembly; Induction of K+ efflux to trigger inflammatory signaling or cell death.